Professor Farhad Ravandi MD
Professor Ravandi is an internationally regarded leukaemia authority at MD Anderson Cancer Centre. He is actively involved in clinical and translational research for the treatment of patients with various hematological malignancies, with a particular focus on leukaemias.
Professor Jeffrey Lancet MD
Professor Lancet is a medical oncologist at the H. Lee Moffitt Cancer Centre whose work involves the development and implementation of clinical trials using small molecule inhibitors in acute leukemias.
Dr. Thomas Prebert MD
Dr Prebet is the Assistant Director of Myeloid Malignancy Research at Yale Cancer Centre, where he is working to expand the clinical and translational research program in myeloid malignancies.
Professor Joshua Douglas
Australian based multiple myeloma authority Professor Joshua Douglas currently heads up Clinical and Laboratory Haematology at the Sydney Cancer Centre and is a former Director of the Institute of Haematology at Royal Prince Alfred Hospital.